Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment

Patients with asthma and Chronic Obstructive Respiratory Disease (COPD) rely on three main device classes for inhalation therapy: metered-dose inhalers (MDIs), dry powder inhalers (DPIs) and soft-mist inhalers (SMIs). The carbon footprint (CF) of these inhalers differs with MDIs having a higher impa...

Descripción completa

Detalles Bibliográficos
Autores principales: Panigone, Sara, Sandri, Federica, Ferri, Rossella, Volpato, Andrea, Nudo, Elena, Nicolini, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Respiratory Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173981/
https://www.ncbi.nlm.nih.gov/pubmed/32238349
http://dx.doi.org/10.1136/bmjresp-2020-000571
_version_ 1783524546992668672
author Panigone, Sara
Sandri, Federica
Ferri, Rossella
Volpato, Andrea
Nudo, Elena
Nicolini, Gabriele
author_facet Panigone, Sara
Sandri, Federica
Ferri, Rossella
Volpato, Andrea
Nudo, Elena
Nicolini, Gabriele
author_sort Panigone, Sara
collection PubMed
description Patients with asthma and Chronic Obstructive Respiratory Disease (COPD) rely on three main device classes for inhalation therapy: metered-dose inhalers (MDIs), dry powder inhalers (DPIs) and soft-mist inhalers (SMIs). The carbon footprint (CF) of these inhalers differs with MDIs having a higher impact than DPIs and SMIs due to the propellant in MDIs. However, the certified CF of specific MDI products may differ significantly. MDIs still represent an essential option for many patients. Consequently, novel approaches shall be considered to balance environmental goals with patient health and well-being while maintaining a diverse range of choices for patients and physicians.
format Online
Article
Text
id pubmed-7173981
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-71739812020-04-27 Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment Panigone, Sara Sandri, Federica Ferri, Rossella Volpato, Andrea Nudo, Elena Nicolini, Gabriele BMJ Open Respir Res Respiratory Research Patients with asthma and Chronic Obstructive Respiratory Disease (COPD) rely on three main device classes for inhalation therapy: metered-dose inhalers (MDIs), dry powder inhalers (DPIs) and soft-mist inhalers (SMIs). The carbon footprint (CF) of these inhalers differs with MDIs having a higher impact than DPIs and SMIs due to the propellant in MDIs. However, the certified CF of specific MDI products may differ significantly. MDIs still represent an essential option for many patients. Consequently, novel approaches shall be considered to balance environmental goals with patient health and well-being while maintaining a diverse range of choices for patients and physicians. BMJ Publishing Group 2020-03-31 /pmc/articles/PMC7173981/ /pubmed/32238349 http://dx.doi.org/10.1136/bmjresp-2020-000571 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Respiratory Research
Panigone, Sara
Sandri, Federica
Ferri, Rossella
Volpato, Andrea
Nudo, Elena
Nicolini, Gabriele
Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment
title Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment
title_full Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment
title_fullStr Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment
title_full_unstemmed Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment
title_short Environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment
title_sort environmental impact of inhalers for respiratory diseases: decreasing the carbon footprint while preserving patient-tailored treatment
topic Respiratory Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173981/
https://www.ncbi.nlm.nih.gov/pubmed/32238349
http://dx.doi.org/10.1136/bmjresp-2020-000571
work_keys_str_mv AT panigonesara environmentalimpactofinhalersforrespiratorydiseasesdecreasingthecarbonfootprintwhilepreservingpatienttailoredtreatment
AT sandrifederica environmentalimpactofinhalersforrespiratorydiseasesdecreasingthecarbonfootprintwhilepreservingpatienttailoredtreatment
AT ferrirossella environmentalimpactofinhalersforrespiratorydiseasesdecreasingthecarbonfootprintwhilepreservingpatienttailoredtreatment
AT volpatoandrea environmentalimpactofinhalersforrespiratorydiseasesdecreasingthecarbonfootprintwhilepreservingpatienttailoredtreatment
AT nudoelena environmentalimpactofinhalersforrespiratorydiseasesdecreasingthecarbonfootprintwhilepreservingpatienttailoredtreatment
AT nicolinigabriele environmentalimpactofinhalersforrespiratorydiseasesdecreasingthecarbonfootprintwhilepreservingpatienttailoredtreatment

Ejemplares similares